Searched for
FAVIPIRAVIR ORAL SUSPENSION
Getting back into shape? 6 Indian pharma stocks with upside potential of up to 41%The year 2024, started with a correction in nifty, but one set of stocks which were able to outperform were pharma stocks. While it might a...- Nifty healthcare index stocks; Staying bullish on select pharma and hospitalsWhile they clubbed together, the operating matrix of a pharma company making drugs and hospital and a diagnostic company are very different...
- Midcap stocks with ‘strong buy’ & ‘buy’ recos can rally over 25%, according to analystsET screener powered by Refinitiv’s Stock Report Plus lists down quality stocks with high upside potential over the next 12 months, having a...
- Midcap stocks with ‘strong buy’ & ‘buy’ recos can rally over 25%, according to analystsET screener powered by Refinitiv’s Stock Report Plus lists down quality stocks with high upside potential over the next 12 months, having a...
- Stocks in the news: Mindtree, HFCL, NMDC, JK Tyres, banks and telcosMindtree, Tata Metaliks, Shree Ganesh Remedies, Deccan Health Care and Gagan Gases will announce quarterly earnings today.
- FDC launches Favipiravir oral suspension to treat COVID-19 in IndiaIn order to combat COVID-19, we believe in offering best efficacy along with convenience to our patients and as such we have focused our ef...
- Bharat Parenterals gets DCGI nod for favipiravir oral suspensionThe company has received licence and authorisation from DCGI to manufacture and market favipiravir oral suspension l00mg/ml, Bharat Parente...
Load More